Generic Name: sofosbuvir / velpatasvir
Applies to sofosbuvir / velpatasvir: oral tablet
In addition to its needed effects, some unwanted effects may be caused by sofosbuvir / velpatasvir. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking sofosbuvir / velpatasvir:
Some of the side effects that can occur with sofosbuvir / velpatasvir may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to sofosbuvir / velpatasvir: oral tablet
The most common side effects reported with this drug were fatigue and headache.  When this drug was studied with ribavirin, the most common side effects were fatigue, anemia, nausea, headache, insomnia, and diarrhea.The manufacturer product information for ribavirin should be consulted, if applicable.[Ref]
Very common (10% or more): Fatigue (up to 32%)Common (1% to 10%): Asthenia, irritability[Ref]
Very common (10% or more): Anemia (26%), decreased hemoglobin (up to 23%)[Ref]
Decreases in hemoglobin to less than 10 g/dL and 8.5 g/dL during combination therapy were reported in 23% and 7% of subjects, respectively.[Ref]
Very common (10% or more): Headache (up to 22%)[Ref]
Very common (10% or more): Nausea (up to 15%)Common (1% to 10%): Diarrhea, increased lipase[Ref]
Isolated, asymptomatic lipase elevations (greater than 3 times the upper limit of normal [3 x ULN]) were reported in up to 6% of subjects.[Ref]
Very common (10% or more): Insomnia (up to 11%)Uncommon (0.1% to 1%): Depressed mood[Ref]
Serious symptomatic bradycardia has been reported in patients taking amiodarone who started therapy with sofosbuvir in combination with another hepatitis C virus (HCV) direct-acting antiviral.[Ref]
Postmarketing reports: Serious symptomatic bradycardia (including fatal cardiac arrest, cases requiring pacemaker intervention)[Ref]
Common (1% to 10%): Rash[Ref]
Common (1% to 10%): Increased creatine kinase[Ref]
Isolated, asymptomatic creatine kinase elevations (at least 10 x ULN) were reported in up to 2% of subjects.[Ref]
Frequency not reported: Increased indirect bilirubin[Ref]
Increased indirect bilirubin (up to 3 mg/dL above baseline) was reported in HIV-1/HCV-coinfected patients using this drug and an atazanavir/ritonavir-based antiretroviral regimen.[Ref]
1. "Product Information. Epclusa (sofosbuvir-velpatasvir)." Gilead Sciences, Foster City, CA. 
Not all side effects for Epclusa may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Chest pain or discomfort
lightheadedness, dizziness or fainting
shortness of breath
slow or irregular heartbeat
unconsciousness
unusual tiredness


Fatigue
headache


Diarrhea
discouragement
feeling sad or empty
irritability
lack of appetite, nausea
lack or loss of strength
loss of interest or pleasure
rash
tiredness
trouble concentrating
trouble sleeping

